Comparative Analysis of Hemagglutination Inhibition Titers Generated Using Temporally Matched Serum and Plasma Samples

Influenza-specific hemaggluitination inhibition (HAI) antibody titer, an indicator of immunity to influenza, is often used to measure exposure to influenza in surveillance and immunogenicity studies. Traditionally, serum has been the specimen of choice for HAI assays, but a desire to reduce the amou...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 7; no. 12; p. e48229
Main Authors Defang, Gabriel N., Martin, Nicholas J., Burgess, Timothy H., Millar, Eugene V., Pecenka, LeNae A., Danko, Janine R., Arnold, John C., Kochel, Tadeusz J., Luke, Thomas C.
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 20.12.2012
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Influenza-specific hemaggluitination inhibition (HAI) antibody titer, an indicator of immunity to influenza, is often used to measure exposure to influenza in surveillance and immunogenicity studies. Traditionally, serum has been the specimen of choice for HAI assays, but a desire to reduce the amount of blood collected during studies and the availability of plasma in archived sample collections warrant the evaluation of plasma for HAI titer. Therefore, the relationship between serum and plasma HAI titer values is of great interest. Here, we compare HAI titers determined on temporally matched serum and plasma (citrated and heparinized) using influenza A and B viruses. Bland-Altman plots, McNemar's test, and geometric coefficient of variation were used respectively for evaluating agreement, correlation and variability in the serum-plasma titer results. We observed a high degree of agreement (80.5%-98.8%) and correlation (r = 0.796-0.964) in the serum and matched plasma titer values although plasma titers were generally lower than corresponding serum titers. Calculated seropositive (HAI ≥40) rates were higher using serum titers than with plasma titers, but seroconversion rates were unaffected by sample type. Stronger agreement and decreased variability in titers were seen between serum and citrated plasma than between serum and heparinized plasma. Overall, these data suggest that serum or plasma can be used in serodiagnostic HAI assays, but seropositive rates may be underestimated using plasma HAI titers. The type of anticoagulant present in plasma may affect HAI titer values and warrants further investigation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
Competing Interests: The authors have declared that no competing interests exist.
Conceived and designed the experiments: GND NJM THB EVM LAP JRD JCA TJK TCL. Performed the experiments: GND LAP. Analyzed the data: GND NJM TJK. Contributed reagents/materials/analysis tools: GND NJM THB EVM JRD JCA TJK TCL. Wrote the paper: GND NJM THB EVM LAP JRD JCA TJK TCL.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0048229